Sterile Liquid formulation comprising an immunoglobulin anti Sclerostin and calcium acetate; use; and the method for reducing the viscosity of a Protein formulation.
Disclosed herein are high concentration antibody formulations comprising an anti-sclerostin immunoglobulin and an acetate salt and/or an acetate buffer and methods of use.FORMULACION LIQUIDA ESTERIL CON UNA VISCOSIDAD ABSOLUTA DE 10CP O MENOR QUE COMPRENDE UNA INMUNOGLOBULINA ANTI-ESCLEROSTINA A UNA CONCENTRACION DE AL MENOS 70 MG/ML Y ACETATO DE CALCIO; METODO PARA REDUCIR LA VISCOSIDAD DE UNA FORMULACION DE PROTEINA A 10CP O MENOS; Y SU USO.